Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis
A Sham-Controlled, Randomized Trial of Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis
1 other identifier
interventional
16
1 country
1
Brief Summary
Chronic pancreatitis leads to severe abdominal pain in up to 70% of patients, and several studies have proposed it has a neuropathic component. Current treatments often fail to provide adequate pain relief, necessitating new innovations for management. Spinal cord stimulation has been proposed to treat severe neuropathic pain refractory to conventional treatment, but sham-controlled trials have not previously been done in patients with visceral pain. This study will test the effect of spinal cord stimulation in chronic pancreatitis patients with insufficient pain relief from standard therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedJanuary 30, 2024
January 1, 2024
2.2 years
January 10, 2024
January 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain relief
The difference in pain intensity scores between active and sham stimulations measured using a patient pain diary based on a numeric rating scale where a score of "0" indicated no pain and a score of "10" indicated worst pain imaginable. Pain scores are registered daily for one week prior to intervention and during the two periods of active and sham SCS stimulations.
At baseline and days 7-10 in each stimulation period
Secondary Outcomes (5)
Patient Global Impression of Change (PGIC)
Immediately after the intervention
The modified Brief Pain Inventory short-form (mBPI-sf)
At baseline an immediately after the intervention
Comprehensive Pain Assessment Tool short-form (COMPAT-sf)
At baseline an immediately after the intervention
Quality of life using SF 36 (short form 36 health survey)
At baseline an immediately after the intervention
Symptoms of depression and anxiety as documented by the Hospital Anxiety and Depression Scale (HADS)
At baseline an immediately after the intervention
Other Outcomes (4)
Quantitative sensory testing: Pressure algometry
At baseline an immediately after the intervention
Quantitative sensory testing: Repetitive pinprick stimulation
At baseline an immediately after the intervention
Quantitative sensory testing: Cold pressor test
At baseline an immediately after the intervention
- +1 more other outcomes
Study Arms (2)
Spinal Cord Stimulation
EXPERIMENTALA stimulation electrode is placed in the epidural space between the T4-T7 spinal levels and connected to an external electrical pulse generator, which is used for stimulation. The stimulus intensity is initially increased in a ramp-like fashion using high-frequency stimulation at 1000 Hz, with pulse widths of 90 microseconds and intensities increasing from 2 to 14 mA to establish the sensation threshold. After establishing the sensation threshold, the 75 % subthreshold of sensation is used as the stimulation intensity during the active stimulation period.
Sham
SHAM COMPARATORFor sham treatment, a similar procedure for establishing the sensation threshold is used, and stimulation at the 75 % subthreshold intensity is initiated, but the stimulation device is turned off 30 seconds after the sensation subthreshold is established.
Interventions
Stimulation electrode tip (Vectris™ SureScan MRI percutaneous lead, Medtronic Inc, Minneapolis, US) External electrical pulse generator (Wireless External Neurostimulator System (WENS), Medtronic)
Stimulation electrode tip (Vectris™ SureScan MRI percutaneous lead, Medtronic Inc, Minneapolis, US) with external stimulator turned off
Eligibility Criteria
You may qualify if:
- Chronic pancreatitis according to the M-ANNHEIM criteria
- Chronic abdominal pain (pain 3=3days per week in at least 3 months)
- Pain insuficiently treated with patients ussual analgesic treatment
- Patients with signs of obstruction of the pancreatic duct due to a stricture or stone have to undergo endoscopic or surgical decompression prior to enrolment
You may not qualify if:
- Patients suffering from painful conditions other than chronic pancreatitis that made them unable to distinguish the pain associated with chronic pancreatitis
- Patients with ongoing alcohol abuse and illegal drug dependencies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastroenterology, Aalborg University Hospital
Aalborg, 9000, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Helga A Gulisano, MD
Aalborg University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 10, 2024
First Posted
January 30, 2024
Study Start
November 1, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
January 30, 2024
Record last verified: 2024-01